nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Application site erythema—Dapsone—leprosy	0.0343	0.0387	CcSEcCtD
Isotretinoin—Application site pruritus—Dapsone—leprosy	0.0331	0.0374	CcSEcCtD
Isotretinoin—Localized exfoliation—Dapsone—leprosy	0.03	0.0339	CcSEcCtD
Isotretinoin—Acquired immunodeficiency syndrome—Thalidomide—leprosy	0.0206	0.0233	CcSEcCtD
Isotretinoin—Teratogenicity—Thalidomide—leprosy	0.0198	0.0223	CcSEcCtD
Isotretinoin—Application site pain—Dapsone—leprosy	0.0184	0.0207	CcSEcCtD
Isotretinoin—Application site reaction—Dapsone—leprosy	0.0172	0.0194	CcSEcCtD
Isotretinoin—Suicide attempt—Dapsone—leprosy	0.0143	0.0161	CcSEcCtD
Isotretinoin—Autoimmune disorder—Thalidomide—leprosy	0.0124	0.014	CcSEcCtD
Isotretinoin—RXRG—eye—leprosy	0.0112	0.0992	CbGeAlD
Isotretinoin—Rales—Thalidomide—leprosy	0.0101	0.0114	CcSEcCtD
Isotretinoin—Dementia—Thalidomide—leprosy	0.0101	0.0114	CcSEcCtD
Isotretinoin—Pericarditis—Thalidomide—leprosy	0.00957	0.0108	CcSEcCtD
Isotretinoin—Erythema nodosum—Thalidomide—leprosy	0.00957	0.0108	CcSEcCtD
Isotretinoin—RARG—eye—leprosy	0.00936	0.0828	CbGeAlD
Isotretinoin—Proteinuria—Dapsone—leprosy	0.00921	0.0104	CcSEcCtD
Isotretinoin—Hyporeflexia—Thalidomide—leprosy	0.00911	0.0103	CcSEcCtD
Isotretinoin—Ascites—Thalidomide—leprosy	0.00911	0.0103	CcSEcCtD
Isotretinoin—Protein urine present—Dapsone—leprosy	0.00908	0.0102	CcSEcCtD
Isotretinoin—White blood cell count decreased—Thalidomide—leprosy	0.00832	0.00938	CcSEcCtD
Isotretinoin—RARG—skin of body—leprosy	0.00815	0.072	CbGeAlD
Isotretinoin—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00809	0.00912	CcSEcCtD
Isotretinoin—Skin exfoliation—Dapsone—leprosy	0.00772	0.00871	CcSEcCtD
Isotretinoin—RARB—tendon—leprosy	0.0076	0.0672	CbGeAlD
Isotretinoin—RXRG—tendon—leprosy	0.00743	0.0657	CbGeAlD
Isotretinoin—Vesiculobullous rash—Thalidomide—leprosy	0.00739	0.00833	CcSEcCtD
Isotretinoin—Foetor hepaticus—Thalidomide—leprosy	0.0073	0.00823	CcSEcCtD
Isotretinoin—Suicide attempt—Thalidomide—leprosy	0.0073	0.00823	CcSEcCtD
Isotretinoin—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00712	0.00803	CcSEcCtD
Isotretinoin—RXRB—tendon—leprosy	0.00699	0.0618	CbGeAlD
Isotretinoin—Febrile neutropenia—Thalidomide—leprosy	0.00688	0.00776	CcSEcCtD
Isotretinoin—RXRA—nervous system—leprosy	0.00688	0.0608	CbGeAlD
Isotretinoin—Serum creatinine increased—Thalidomide—leprosy	0.00673	0.00759	CcSEcCtD
Isotretinoin—Embolism—Thalidomide—leprosy	0.00645	0.00727	CcSEcCtD
Isotretinoin—Nail disorder—Thalidomide—leprosy	0.00638	0.0072	CcSEcCtD
Isotretinoin—RARG—tendon—leprosy	0.0062	0.0548	CbGeAlD
Isotretinoin—RXRG—testis—leprosy	0.00615	0.0544	CbGeAlD
Isotretinoin—Menstrual disorder—Thalidomide—leprosy	0.00607	0.00685	CcSEcCtD
Isotretinoin—Liver disorder—Thalidomide—leprosy	0.00607	0.00685	CcSEcCtD
Isotretinoin—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00607	0.00685	CcSEcCtD
Isotretinoin—RXRG—nervous system—leprosy	0.00604	0.0534	CbGeAlD
Isotretinoin—Hypercalcaemia—Thalidomide—leprosy	0.00596	0.00672	CcSEcCtD
Isotretinoin—Cyanosis—Thalidomide—leprosy	0.00585	0.0066	CcSEcCtD
Isotretinoin—Thrombosis—Thalidomide—leprosy	0.00585	0.0066	CcSEcCtD
Isotretinoin—Lung disorder—Thalidomide—leprosy	0.00585	0.0066	CcSEcCtD
Isotretinoin—RARA—tendon—leprosy	0.00583	0.0516	CbGeAlD
Isotretinoin—RXRB—testis—leprosy	0.00579	0.0512	CbGeAlD
Isotretinoin—Hyperlipidaemia—Thalidomide—leprosy	0.00574	0.00648	CcSEcCtD
Isotretinoin—Psychotic disorder—Dapsone—leprosy	0.00573	0.00647	CcSEcCtD
Isotretinoin—RXRB—nervous system—leprosy	0.00568	0.0502	CbGeAlD
Isotretinoin—Pleural effusion—Thalidomide—leprosy	0.00541	0.0061	CcSEcCtD
Isotretinoin—Skin ulcer—Thalidomide—leprosy	0.00532	0.006	CcSEcCtD
Isotretinoin—Hyperaesthesia—Thalidomide—leprosy	0.00528	0.00595	CcSEcCtD
Isotretinoin—Nasopharyngitis—Dapsone—leprosy	0.00525	0.00592	CcSEcCtD
Isotretinoin—Rash pustular—Thalidomide—leprosy	0.00519	0.00585	CcSEcCtD
Isotretinoin—Tingling sensation—Thalidomide—leprosy	0.00515	0.00581	CcSEcCtD
Isotretinoin—RARG—testis—leprosy	0.00514	0.0454	CbGeAlD
Isotretinoin—RARG—nervous system—leprosy	0.00504	0.0446	CbGeAlD
Isotretinoin—Numbness—Thalidomide—leprosy	0.005	0.00563	CcSEcCtD
Isotretinoin—Pancreatitis—Dapsone—leprosy	0.00498	0.00561	CcSEcCtD
Isotretinoin—Acne—Thalidomide—leprosy	0.00492	0.00555	CcSEcCtD
Isotretinoin—RARA—testis—leprosy	0.00483	0.0427	CbGeAlD
Isotretinoin—Sensory loss—Thalidomide—leprosy	0.00478	0.00539	CcSEcCtD
Isotretinoin—RARA—nervous system—leprosy	0.00474	0.0419	CbGeAlD
Isotretinoin—Proteinuria—Thalidomide—leprosy	0.00471	0.00531	CcSEcCtD
Isotretinoin—Protein urine present—Thalidomide—leprosy	0.00465	0.00524	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Dapsone—leprosy	0.00463	0.00522	CcSEcCtD
Isotretinoin—Musculoskeletal stiffness—Thalidomide—leprosy	0.00462	0.0052	CcSEcCtD
Isotretinoin—Skin discolouration—Thalidomide—leprosy	0.00458	0.00517	CcSEcCtD
Isotretinoin—Cellulitis—Thalidomide—leprosy	0.00455	0.00513	CcSEcCtD
Isotretinoin—Herpes simplex—Thalidomide—leprosy	0.00449	0.00507	CcSEcCtD
Isotretinoin—Drug interaction—Thalidomide—leprosy	0.00446	0.00503	CcSEcCtD
Isotretinoin—Hyperuricaemia—Thalidomide—leprosy	0.00446	0.00503	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Dapsone—leprosy	0.00444	0.005	CcSEcCtD
Isotretinoin—Leukocytosis—Thalidomide—leprosy	0.00441	0.00497	CcSEcCtD
Isotretinoin—Hypercholesterolaemia—Thalidomide—leprosy	0.00438	0.00494	CcSEcCtD
Isotretinoin—Hearing impaired—Thalidomide—leprosy	0.00435	0.0049	CcSEcCtD
Isotretinoin—Bone pain—Thalidomide—leprosy	0.00432	0.00487	CcSEcCtD
Isotretinoin—Sinusitis—Dapsone—leprosy	0.00425	0.00479	CcSEcCtD
Isotretinoin—Gait disturbance—Thalidomide—leprosy	0.00424	0.00478	CcSEcCtD
Isotretinoin—Blood uric acid increased—Thalidomide—leprosy	0.00422	0.00475	CcSEcCtD
Isotretinoin—Neck pain—Thalidomide—leprosy	0.00419	0.00473	CcSEcCtD
Isotretinoin—Phosphatase alkaline increased—Thalidomide—leprosy	0.00414	0.00467	CcSEcCtD
Isotretinoin—Hepatocellular injury—Thalidomide—leprosy	0.00414	0.00467	CcSEcCtD
Isotretinoin—Pharyngitis—Dapsone—leprosy	0.00403	0.00455	CcSEcCtD
Isotretinoin—Depressed level of consciousness—Thalidomide—leprosy	0.004	0.00451	CcSEcCtD
Isotretinoin—Colitis—Thalidomide—leprosy	0.00398	0.00448	CcSEcCtD
Isotretinoin—Skin exfoliation—Thalidomide—leprosy	0.00395	0.00446	CcSEcCtD
Isotretinoin—Candida infection—Thalidomide—leprosy	0.00395	0.00446	CcSEcCtD
Isotretinoin—Dry eye—Thalidomide—leprosy	0.00382	0.00431	CcSEcCtD
Isotretinoin—Tinnitus—Dapsone—leprosy	0.00379	0.00427	CcSEcCtD
Isotretinoin—Oesophagitis—Thalidomide—leprosy	0.00378	0.00427	CcSEcCtD
Isotretinoin—Rash maculo-papular—Thalidomide—leprosy	0.00376	0.00424	CcSEcCtD
Isotretinoin—Lightheadedness—Thalidomide—leprosy	0.0037	0.00418	CcSEcCtD
Isotretinoin—Pulmonary oedema—Thalidomide—leprosy	0.00369	0.00416	CcSEcCtD
Isotretinoin—Sepsis—Thalidomide—leprosy	0.00359	0.00405	CcSEcCtD
Isotretinoin—Euphoric mood—Thalidomide—leprosy	0.00356	0.00401	CcSEcCtD
Isotretinoin—Erythema—Dapsone—leprosy	0.00354	0.00399	CcSEcCtD
Isotretinoin—Lymphadenopathy—Thalidomide—leprosy	0.00352	0.00397	CcSEcCtD
Isotretinoin—Diabetes mellitus—Thalidomide—leprosy	0.00346	0.0039	CcSEcCtD
Isotretinoin—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00346	0.0039	CcSEcCtD
Isotretinoin—Photosensitivity—Thalidomide—leprosy	0.00342	0.00386	CcSEcCtD
Isotretinoin—Deafness—Thalidomide—leprosy	0.00336	0.00379	CcSEcCtD
Isotretinoin—Eczema—Thalidomide—leprosy	0.00334	0.00377	CcSEcCtD
Isotretinoin—Vision blurred—Dapsone—leprosy	0.00333	0.00376	CcSEcCtD
Isotretinoin—Cardiac failure congestive—Thalidomide—leprosy	0.00331	0.00374	CcSEcCtD
Isotretinoin—Renal failure acute—Thalidomide—leprosy	0.00326	0.00367	CcSEcCtD
Isotretinoin—Dermatitis exfoliative—Thalidomide—leprosy	0.00319	0.00359	CcSEcCtD
Isotretinoin—Visual disturbance—Thalidomide—leprosy	0.00317	0.00358	CcSEcCtD
Isotretinoin—Dermatitis bullous—Thalidomide—leprosy	0.00314	0.00355	CcSEcCtD
Isotretinoin—Arthritis—Thalidomide—leprosy	0.00309	0.00349	CcSEcCtD
Isotretinoin—Cough—Dapsone—leprosy	0.00309	0.00348	CcSEcCtD
Isotretinoin—Cardiac failure—Thalidomide—leprosy	0.00308	0.00347	CcSEcCtD
Isotretinoin—Lethargy—Thalidomide—leprosy	0.00307	0.00346	CcSEcCtD
Isotretinoin—Cerebrovascular accident—Thalidomide—leprosy	0.00307	0.00346	CcSEcCtD
Isotretinoin—Osteoarthritis—Thalidomide—leprosy	0.00301	0.00339	CcSEcCtD
Isotretinoin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00301	0.00339	CcSEcCtD
Isotretinoin—Pain in extremity—Thalidomide—leprosy	0.00301	0.00339	CcSEcCtD
Isotretinoin—Affect lability—Thalidomide—leprosy	0.00296	0.00334	CcSEcCtD
Isotretinoin—Psychotic disorder—Thalidomide—leprosy	0.00294	0.00331	CcSEcCtD
Isotretinoin—Face oedema—Thalidomide—leprosy	0.0029	0.00327	CcSEcCtD
Isotretinoin—Cardiac arrest—Thalidomide—leprosy	0.00286	0.00322	CcSEcCtD
Isotretinoin—Mood swings—Thalidomide—leprosy	0.00285	0.00321	CcSEcCtD
Isotretinoin—Tachycardia—Dapsone—leprosy	0.00282	0.00318	CcSEcCtD
Isotretinoin—Blood creatinine increased—Thalidomide—leprosy	0.00282	0.00317	CcSEcCtD
Isotretinoin—Dehydration—Thalidomide—leprosy	0.0028	0.00315	CcSEcCtD
Isotretinoin—Dry skin—Thalidomide—leprosy	0.00276	0.00311	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00271	0.00305	CcSEcCtD
Isotretinoin—Abdominal distension—Thalidomide—leprosy	0.00262	0.00295	CcSEcCtD
Isotretinoin—Insomnia—Dapsone—leprosy	0.00261	0.00294	CcSEcCtD
Isotretinoin—Dysphagia—Thalidomide—leprosy	0.0026	0.00293	CcSEcCtD
Isotretinoin—Bronchospasm—Thalidomide—leprosy	0.00256	0.00288	CcSEcCtD
Isotretinoin—Pancreatitis—Thalidomide—leprosy	0.00255	0.00287	CcSEcCtD
Isotretinoin—Neutropenia—Thalidomide—leprosy	0.00243	0.00274	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Thalidomide—leprosy	0.00241	0.00272	CcSEcCtD
Isotretinoin—Pollakiuria—Thalidomide—leprosy	0.0024	0.00271	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Thalidomide—leprosy	0.00237	0.00267	CcSEcCtD
Isotretinoin—Weight increased—Thalidomide—leprosy	0.00236	0.00267	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Dapsone—leprosy	0.00236	0.00266	CcSEcCtD
Isotretinoin—Weight decreased—Thalidomide—leprosy	0.00235	0.00265	CcSEcCtD
Isotretinoin—Pneumonia—Thalidomide—leprosy	0.00233	0.00263	CcSEcCtD
Isotretinoin—Infestation NOS—Thalidomide—leprosy	0.00232	0.00261	CcSEcCtD
Isotretinoin—Infestation—Thalidomide—leprosy	0.00232	0.00261	CcSEcCtD
Isotretinoin—Drowsiness—Thalidomide—leprosy	0.00232	0.00261	CcSEcCtD
Isotretinoin—Depression—Thalidomide—leprosy	0.00231	0.0026	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.0023	0.00259	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Thalidomide—leprosy	0.00228	0.00257	CcSEcCtD
Isotretinoin—Abdominal pain—Dapsone—leprosy	0.00228	0.00257	CcSEcCtD
Isotretinoin—Body temperature increased—Dapsone—leprosy	0.00228	0.00257	CcSEcCtD
Isotretinoin—Renal failure—Thalidomide—leprosy	0.00228	0.00257	CcSEcCtD
Isotretinoin—Myocardial infarction—Thalidomide—leprosy	0.00227	0.00256	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Thalidomide—leprosy	0.00227	0.00256	CcSEcCtD
Isotretinoin—Stomatitis—Thalidomide—leprosy	0.00226	0.00255	CcSEcCtD
Isotretinoin—Conjunctivitis—Thalidomide—leprosy	0.00225	0.00254	CcSEcCtD
Isotretinoin—Sweating—Thalidomide—leprosy	0.00222	0.0025	CcSEcCtD
Isotretinoin—Haematuria—Thalidomide—leprosy	0.00221	0.00249	CcSEcCtD
Isotretinoin—Epistaxis—Thalidomide—leprosy	0.00218	0.00246	CcSEcCtD
Isotretinoin—Sinusitis—Thalidomide—leprosy	0.00217	0.00245	CcSEcCtD
Isotretinoin—Agranulocytosis—Thalidomide—leprosy	0.00216	0.00244	CcSEcCtD
Isotretinoin—Hepatitis—Thalidomide—leprosy	0.00208	0.00234	CcSEcCtD
Isotretinoin—Hypoaesthesia—Thalidomide—leprosy	0.00207	0.00233	CcSEcCtD
Isotretinoin—Pharyngitis—Thalidomide—leprosy	0.00206	0.00233	CcSEcCtD
Isotretinoin—Urinary tract disorder—Thalidomide—leprosy	0.00205	0.00232	CcSEcCtD
Isotretinoin—Oedema peripheral—Thalidomide—leprosy	0.00205	0.00231	CcSEcCtD
Isotretinoin—Urethral disorder—Thalidomide—leprosy	0.00204	0.0023	CcSEcCtD
Isotretinoin—Visual impairment—Thalidomide—leprosy	0.002	0.00226	CcSEcCtD
Isotretinoin—Erythema multiforme—Thalidomide—leprosy	0.00197	0.00222	CcSEcCtD
Isotretinoin—Eye disorder—Thalidomide—leprosy	0.00194	0.00219	CcSEcCtD
Isotretinoin—Tinnitus—Thalidomide—leprosy	0.00194	0.00219	CcSEcCtD
Isotretinoin—Angiopathy—Thalidomide—leprosy	0.00189	0.00213	CcSEcCtD
Isotretinoin—Chills—Thalidomide—leprosy	0.00187	0.0021	CcSEcCtD
Isotretinoin—Arrhythmia—Thalidomide—leprosy	0.00186	0.00209	CcSEcCtD
Isotretinoin—Alopecia—Thalidomide—leprosy	0.00184	0.00207	CcSEcCtD
Isotretinoin—Vomiting—Dapsone—leprosy	0.00183	0.00207	CcSEcCtD
Isotretinoin—Mental disorder—Thalidomide—leprosy	0.00182	0.00205	CcSEcCtD
Isotretinoin—Malnutrition—Thalidomide—leprosy	0.00181	0.00204	CcSEcCtD
Isotretinoin—Headache—Dapsone—leprosy	0.00181	0.00204	CcSEcCtD
Isotretinoin—Flatulence—Thalidomide—leprosy	0.00178	0.00201	CcSEcCtD
Isotretinoin—Tension—Thalidomide—leprosy	0.00178	0.002	CcSEcCtD
Isotretinoin—Nervousness—Thalidomide—leprosy	0.00176	0.00198	CcSEcCtD
Isotretinoin—Back pain—Thalidomide—leprosy	0.00175	0.00197	CcSEcCtD
Isotretinoin—Nausea—Dapsone—leprosy	0.00171	0.00193	CcSEcCtD
Isotretinoin—Vision blurred—Thalidomide—leprosy	0.00171	0.00192	CcSEcCtD
Isotretinoin—Tremor—Thalidomide—leprosy	0.0017	0.00191	CcSEcCtD
Isotretinoin—Ill-defined disorder—Thalidomide—leprosy	0.00168	0.00189	CcSEcCtD
Isotretinoin—Anaemia—Thalidomide—leprosy	0.00167	0.00189	CcSEcCtD
Isotretinoin—Agitation—Thalidomide—leprosy	0.00166	0.00188	CcSEcCtD
Isotretinoin—Malaise—Thalidomide—leprosy	0.00163	0.00184	CcSEcCtD
Isotretinoin—Syncope—Thalidomide—leprosy	0.00162	0.00183	CcSEcCtD
Isotretinoin—Palpitations—Thalidomide—leprosy	0.0016	0.0018	CcSEcCtD
Isotretinoin—Loss of consciousness—Thalidomide—leprosy	0.00159	0.00179	CcSEcCtD
Isotretinoin—Cough—Thalidomide—leprosy	0.00158	0.00178	CcSEcCtD
Isotretinoin—Convulsion—Thalidomide—leprosy	0.00157	0.00177	CcSEcCtD
Isotretinoin—Hypertension—Thalidomide—leprosy	0.00156	0.00176	CcSEcCtD
Isotretinoin—Chest pain—Thalidomide—leprosy	0.00154	0.00174	CcSEcCtD
Isotretinoin—Myalgia—Thalidomide—leprosy	0.00154	0.00174	CcSEcCtD
Isotretinoin—Arthralgia—Thalidomide—leprosy	0.00154	0.00174	CcSEcCtD
Isotretinoin—Anxiety—Thalidomide—leprosy	0.00154	0.00173	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00153	0.00173	CcSEcCtD
Isotretinoin—Discomfort—Thalidomide—leprosy	0.00152	0.00172	CcSEcCtD
Isotretinoin—Dry mouth—Thalidomide—leprosy	0.00151	0.0017	CcSEcCtD
Isotretinoin—Confusional state—Thalidomide—leprosy	0.00149	0.00168	CcSEcCtD
Isotretinoin—Oedema—Thalidomide—leprosy	0.00148	0.00167	CcSEcCtD
Isotretinoin—Infection—Thalidomide—leprosy	0.00147	0.00165	CcSEcCtD
Isotretinoin—Shock—Thalidomide—leprosy	0.00145	0.00164	CcSEcCtD
Isotretinoin—Nervous system disorder—Thalidomide—leprosy	0.00145	0.00163	CcSEcCtD
Isotretinoin—Thrombocytopenia—Thalidomide—leprosy	0.00145	0.00163	CcSEcCtD
Isotretinoin—Tachycardia—Thalidomide—leprosy	0.00144	0.00163	CcSEcCtD
Isotretinoin—Skin disorder—Thalidomide—leprosy	0.00143	0.00162	CcSEcCtD
Isotretinoin—Hyperhidrosis—Thalidomide—leprosy	0.00143	0.00161	CcSEcCtD
Isotretinoin—Anorexia—Thalidomide—leprosy	0.00141	0.00159	CcSEcCtD
Isotretinoin—Hypotension—Thalidomide—leprosy	0.00138	0.00156	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00135	0.00152	CcSEcCtD
Isotretinoin—Insomnia—Thalidomide—leprosy	0.00134	0.00151	CcSEcCtD
Isotretinoin—Paraesthesia—Thalidomide—leprosy	0.00133	0.0015	CcSEcCtD
Isotretinoin—Dyspnoea—Thalidomide—leprosy	0.00132	0.00149	CcSEcCtD
Isotretinoin—Somnolence—Thalidomide—leprosy	0.00131	0.00148	CcSEcCtD
Isotretinoin—Dyspepsia—Thalidomide—leprosy	0.0013	0.00147	CcSEcCtD
Isotretinoin—Decreased appetite—Thalidomide—leprosy	0.00128	0.00145	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Thalidomide—leprosy	0.00128	0.00144	CcSEcCtD
Isotretinoin—Fatigue—Thalidomide—leprosy	0.00127	0.00144	CcSEcCtD
Isotretinoin—Pain—Thalidomide—leprosy	0.00126	0.00142	CcSEcCtD
Isotretinoin—Constipation—Thalidomide—leprosy	0.00126	0.00142	CcSEcCtD
Isotretinoin—Feeling abnormal—Thalidomide—leprosy	0.00122	0.00137	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Thalidomide—leprosy	0.00121	0.00136	CcSEcCtD
Isotretinoin—Urticaria—Thalidomide—leprosy	0.00117	0.00132	CcSEcCtD
Isotretinoin—Abdominal pain—Thalidomide—leprosy	0.00117	0.00132	CcSEcCtD
Isotretinoin—Body temperature increased—Thalidomide—leprosy	0.00117	0.00132	CcSEcCtD
Isotretinoin—Hypersensitivity—Thalidomide—leprosy	0.00109	0.00123	CcSEcCtD
Isotretinoin—Asthenia—Thalidomide—leprosy	0.00106	0.0012	CcSEcCtD
Isotretinoin—Pruritus—Thalidomide—leprosy	0.00105	0.00118	CcSEcCtD
Isotretinoin—Diarrhoea—Thalidomide—leprosy	0.00101	0.00114	CcSEcCtD
Isotretinoin—Dizziness—Thalidomide—leprosy	0.000977	0.0011	CcSEcCtD
Isotretinoin—Vomiting—Thalidomide—leprosy	0.000939	0.00106	CcSEcCtD
Isotretinoin—Rash—Thalidomide—leprosy	0.000931	0.00105	CcSEcCtD
Isotretinoin—Dermatitis—Thalidomide—leprosy	0.000931	0.00105	CcSEcCtD
Isotretinoin—Headache—Thalidomide—leprosy	0.000925	0.00104	CcSEcCtD
Isotretinoin—Nausea—Thalidomide—leprosy	0.000878	0.000989	CcSEcCtD
